Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Urology and Nephrology
Published in: International Urology and Nephrology 1/2009

01-03-2009 | Letter

Effect of HCV infection on hematocrit and hemoglobin level in Egyptian hemodialysis patients

Authors: Alaa Abdel-Aziz Sabry, Khaled F. El-Dahshan, Khaled M. Mahmoud, Amr A El-Husseini

Published in: International Urology and Nephrology | Issue 1/2009

Login to get access

Excerpt

The prevalence of HCV infection in patients undergoing dialysis is persistently greater than that in the general population [1]. It is endemic in hemodialysis (HD) units around the world, predominantly in Mediterranean and developing countries of the Middle and Far East. Nosocomial transmission of HCV has been reported to be the major route of HCV infection in modern hospital dialysis units. …
Literature
1.
Djordjevic V, Stojanovic K, Stojanovic M, Stefanovic V (2000) Prevention of nosocomial transmission of hepatitis C infection in a hemodialysis unit. A prospective study. Int J Artif Organs 23:181–188PubMed
2.
Sabry AA, Sobh MA, Irving WL et al (2002) A comprehensive study of the association between hepatitis C virus and glomerulopathy. Nephrol Dial Transplant 17:239–245PubMedCrossRef
3.
Wasley A, Alter MJ (2000) Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 20:1–16PubMedCrossRef
4.
Mahmoud IM, Sobh MA, Amer MG, El-Chenawy FA, Gazareen SH, El-Sherif A et al (1999) A prospective study of hepatitis C viremia in renal allograft recipients. Am J Nephrol 19:576–585PubMedCrossRef
5.
Fabrizi F, Martin P (2001) Hepatitis C virus infection in dialysis: an emerging clinical reality. Int J Artif Organs 24:123–130PubMed
6.
Pereira BJG (1999) Hepatitis C virus infection in dialysis: a continuing problem. Art Orgns 23:51–60CrossRef
7.
Weiner AJ, Kuo G, Bradley DW et al (1990) detection of hepatitis viral sequences in non-A, non-B hepatitis. Lancet 335:1–3PubMedCrossRef
8.
Faquin WC, Schneider TJ, Goldberg MA (1992) Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood 79:1987–1994PubMed
9.
Radovic M, Jelkmann W, Djukanovic L, Ostric V (1999) Serum erythropoietin and interleukin-6 levels in hemodialysis patients with hepatitis virus infection. J Interferon Cytokine Res 19:369–373PubMedCrossRef
10.
Sahin I, Arabaci F, Sahin HA, Ilhan M, Ustun Y, Mercan R, Eminov L (2003) Does hepatitis C virus infection increase hematocrit and hemoglobin levels in hemodialyzed patients? Clin Nephrol 60(6):401–404PubMed
11.
Chan N, Barton C, Mirahamdi MS, Gordon S, Vaziri ND (1984) Erythropoiesis associated with viral hepatitis in end—stage renal disease. Am J Med Sci 287:56–58PubMedCrossRef
12.
Simon P, Meyrier A, Tanquerel T, Ang KS (1980) Improvement of anemia in hemodialyzed patients after viral or toxic hepatic cytolysis. Br Med J 280:892–894PubMedCrossRef
13.
Radovic M,Jelkmann W, djukanovic L, Ostric V (1999) Serum erythropoietin and interlukin-6 levels in hemodialysis patients with hepatitis virus infection. J Interferon Cytokine Res 19:69–73CrossRef
14.
Abdalla AH, Owda AK, Fedail H et al (2000) Influence of hepatitis C virus infection upon parenteral iron and erythropoietin responsiveness in regular hemodialysis patients. Nephron 84:293–294PubMedCrossRef
15.
Ali Özdemir, Berrin Yali Nba, Umut Selamet, Meltem Eres, Berna Murat, Reiza U Gursu, Yildiz Barut (2005) Relationship between iron replacement and hepatic functions in hepatitis C virus-positive chronic haemodialysis patients. Nephrology(Carlton) 10:433–437
16.
Sabry AA, Sobh MA, Sheaashaa HA, Kudesia G, Wild G, Fox2 S, Wagner BE, Irving WL, Grabowska A, El-Nahas AM (2002) Effect of combination therapy (ribavirin and interferon) in HCV-related glomerulopathy. Nephrol Dial Transplant 17:1924–1930
Metadata
Title
Effect of HCV infection on hematocrit and hemoglobin level in Egyptian hemodialysis patients
Authors
Alaa Abdel-Aziz Sabry
Khaled F. El-Dahshan
Khaled M. Mahmoud
Amr A El-Husseini
Publication date
01-03-2009
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 1/2009
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-006-9092-7

Other articles of this Issue 1/2009

International Urology and Nephrology 1/2009 Go to the issue

Urology-Original Paper

Quality of life of neurogenic patients: translation and validation of the Portuguese version of Qualiveen

Nephrology - Review

Renal effects of dual renin–angiotensin–aldosterone system blockade in patients with diabetic nephropathy

Urology - Original Paper

Glutathione peroxidase 1 (GPX1) genetic polymorphism, erythrocyte GPX activity, and prostate cancer risk

Nephrology - Original Paper

The effects of percutaneous nephrolithotomy on renal function in geriatric patients in the early postoperative period

Urology - Review

Ewing’s sarcoma of the urogenital tract

Urology-Original Paper

The significance of microscopic bladder neck invasion in radical prostatectomies: pT4 disease?
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits